Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids

Details for Australian Patent Application No. 2005259685 (hide)

Owner Statens Serum Institut

Inventors Andersen, Peter; Davidsen, Jesper; Rosenkrands, Ida

Agent Pegasus IP

Pub. Number AU-B-2005259685

PCT Pub. Number WO2006/002642

Priority PA 2004 01070 07.07.04 DK

Filing date 5 July 2005

Wipo publication date 12 January 2006

Acceptance publication date 8 April 2010

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 39/015 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

A61K 39/118 (2006.01) Medicinal preparations containing antigens or antibodies - Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/002642 Priority application(s): WO2006/002642

8 April 2010 Application Accepted

  Published as AU-B-2005259685

5 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259686-Alpha-amylase variants with altered properties

2005259676-Tetrahydroquinolines